There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
November 2019: The Eleventh Circuit Court of Appeals concluded that the plaintiffs adequately alleged injury in their complaint and that the district court erred in finding that the plaintiffs did not have standing. The dismissal was vacated and the case was remanded for further proceedings.
April 2018: The plaintiffs filed a Notice of Appeal regarding the dismissal order.
March 2018: A federal judge dismissed this case concluding that the plaintiffs did not have standing because they did not adequately allege that they suffered an injury.
April 2017: A false advertising lawsuit was filed against IQ Formulations alleging that the company fails to disclose that Metabolic Nutrition dietary supplements – specifically, Synedrex and E.S.P. (Energy Stimulant Pre-Workout) – contain an unlawful ingredient, MethylPentane Citrate (more commonly known as DMBA) and the failure to disclose this information violates state and federal law. (DeBernardis et al v. IQ Formulations, LLC and Europa Sports Products, Inc., Case No. 17-cv-21562, S. D. FL.)
For more information about the marketing of dietary supplements, click here.
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
Letters alert agencies and organizations to company’s improper marketing.
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
New research points to “no.”
Why disclosures are key to protecting informed consumer choice and competition.